ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0027

Cation Channel TRPC1 Regulates Mesenchymal Stem Cell Differentiation and Bone Formation

Jyoti Yadav1, Shivmurat Yadav2, Jeremy Houser1, Marta Onopuik3, Leonidas Tsiokas3 and Mary Beth Humphrey1, 1University of Oklahoma College of Medicine, Oklahoma City, OK, 2University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3University of Oklahoma College of Medicine, Oklahoma City

Meeting: ACR Convergence 2024

Keywords: bone biology, Bone density, Mouse, osteoblast

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Transient receptor potential canonical 1 (TRPC1), a non-selective cation channel, is characterized by its high permeability to calcium ions (Ca2+), a vital second messenger for numerous cellular functions. MSCs can differentiate into multiple cell lineages, including osteoblasts, chondrocytes, and adipocytes.  Our prior study showed that mice with global deletion of TRPC1 had higher bone mass, but this was in the setting of the mice having hyperparathyroidism.  To further elucidate the role of TRPC1 in modulating bone remodeling homeostasis, we generated MSC-specific TRPC1-deficient mice (TRPC1-KOMSC).

Methods: TRPC1ex-2 flox/flox (f/f) females were crossed with Prrx1Cre+; TRPC1f/f males to generate TRPC1-KOMSC and Cre- negative control mice. At 15 weeks, microCT was performed on male and female tibial trabecular and cortical bones, and dynamic and static histomorphology. Osteoclast numbers (N.Oc.) were quantified by TRAP staining. MSC was quantified by flow cytometry (Ter119–, CD45–, PDGFRα+, Sca1+ and LepR+) and colony forming units (CFU).  In vitro, MSCs were differentiated into osteoblasts for 21 days or adipocytes for 7 days using osteogenic and adipogenic specific media, respectively. Differentiation was confirmed with Alizarin Red S and Oil Red O staining for osteoblast and adipocyte.

Results: Micro-CT assessment of tibial trabecular bone from 15-week-old male and female TRPC1-KOMSC and Cre negative littermates revealed significantly increased bone volume/tissue volume (BV/TV), connectivity density (Conn.D.), and trabecular number (Tb.N.), and decreased trabecular spacing (Tb.Sp.) (Fig1). Osteoid surface (OS) and number of osteoblasts (N.Ob.) were elevated in TRPC1-KOMSC mice compared to controls (Fig2A). Dynamic bone analysis showed a significant increase in mineral apposition rate (MAR) in female TRPC1-KOMSC mice (Fig2B). No significant differences were observed in cortical bone parameters. Numbers of PDFGRa+/SCa1+ MSC were similar independent of TRPC1 expression, but LepR+ MSC were increased in TRPC1-KOMSC compared to WT mice.  The proliferation of MSC assessed by Ki67 staining was significantly decreased in TRPC1-KOMSC compared to WT mice, but CFU was similar.  MSC derived from TRPC1-KOMSC mice induced significantly faster OB differentiation than WT MSC. TRPC1-deficient MSC differentiated with adipogenic media formed significantly more mature adipocytes than WT MSC (Fig3A &B). 

Conclusion: These studies reveal negative regulation of bone homeostasis by TRPC1 expression in MSC.  In vivo, MSC-specific TRPC1-deficiency increases osteoblast numbers, increases osteoid production, and leads to higher bone mass.  The osteoclast compartment was unchanged. MSC-specific TRPC1-deficiency leads to increased LepR+/Sca1/PDGFRa+ MSC that have increased commitment to osteoblasts and adipocytes, suggesting that TRPC1 negatively regulates the early MSC differentiation of LepR+ MSC. These findings highlight TRPC1 as a potential therapeutic target for enhancing bone health and treating bone loss-related conditions and bone regeneration.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: J. Yadav: None; S. Yadav: None; J. Houser: None; M. Onopuik: None; L. Tsiokas: None; M. Humphrey: None.

To cite this abstract in AMA style:

Yadav J, Yadav S, Houser J, Onopuik M, Tsiokas L, Humphrey M. Cation Channel TRPC1 Regulates Mesenchymal Stem Cell Differentiation and Bone Formation [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/cation-channel-trpc1-regulates-mesenchymal-stem-cell-differentiation-and-bone-formation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cation-channel-trpc1-regulates-mesenchymal-stem-cell-differentiation-and-bone-formation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology